Reaction
Pneumonia Cryptococcal reporting signals
As of the last recalculation, Pneumonia Cryptococcal appears in 922 FAERS reports alongside 33 co-occurring drug terms. The strongest observed disproportionality signal is AMPHOTERICIN B (PRR 63.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Amphotericin B | 34 | 63.6 | 63.7 |
| Mycophenilic Acid | 51 | 58.8 | 58.9 |
| Remdesivir | 30 | 52.5 | 52.6 |
| Basiliximab | 21 | 41.2 | 41.3 |
| Mycophenolic Acid | 55 | 41.2 | 41.3 |
| Tacrolimus Ointment 0.1% | 176 | 39.2 | 39.3 |
| Tacrolimus Extended-Release Capsules | 176 | 39.1 | 39.1 |
| Tacrolimus | 190 | 34.2 | 34.3 |
| Valganciclovir Hydrochloride Powder, | 18 | 34.0 | 34.0 |
| Fluconazole | 78 | 27.4 | 27.4 |
| Ganciclovir Sodium | 12 | 25.9 | 26.0 |
| Mycophenolate Mofetil | 127 | 24.3 | 24.3 |
| Mycophenolate Mofetil Hydrochloride | 127 | 24.3 | 24.3 |
| Ganciclovir | 10 | 22.3 | 22.3 |
| Valganciclovir | 18 | 22.0 | 22.0 |
| Valganciclovir Hydrochloride | 18 | 22.0 | 22.0 |
| Prednisolone | 137 | 20.0 | 20.0 |
| Prednisolone Oral | 137 | 20.0 | 20.0 |
| Prednisolone Oral Solution | 137 | 20.0 | 20.0 |
| Isoniazid | 14 | 19.8 | 19.8 |
| Tofacitinib Citrate | 11 | 19.2 | 19.2 |
| Daspone | 8 | 18.7 | 18.7 |
| Dapsone Gel, 5% | 8 | 18.7 | 18.7 |
| Dapsone | 8 | 17.1 | 17.1 |
| Voriconazole Injection | 13 | 13.7 | 13.7 |
| Voriconazole | 18 | 13.6 | 13.6 |
| Dolutegravir Sodium | 5 | 12.6 | 12.6 |
| Baricitinib | 5 | 11.8 | 11.8 |
| Erlotinib | 5 | 11.7 | 11.7 |
| Ibrutinib | 33 | 9.5 | 9.5 |
| Erlotinib Hydrochloride | 5 | 9.1 | 9.1 |
| Brentuximab Vedotin | 4 | 8.8 | 8.8 |
| Temozolomide | 8 | 8.6 | 8.6 |